Taiwan FDA registration 744c30cbc093ebf7cbb53123a7f483a8
“Sebia” IT/IF Control
TW: “賽比亞” 免疫分型/免疫固定電泳品管液
Taiwan·Risk Class 2·MD·SEBIA·Registered Jun 03, 2016 – Jun 03, 2026ExpiredRegistration details
- Analysis ID
- 744c30cbc093ebf7cbb53123a7f483a8
- License Form
- Ministry of Health Medical Device Import No. 028439
- Customs Code
- DHA05602843909
Company information
- Manufacturer
- SEBIA
- Manufacturer Country
- France
- Authorized Representative
- ARQon Medtech Co., Ltd.
Product details
- Intended Use
- This immunophenotyping/immunofixation electrophoresis solution is designed as a quality control substance for the legal detection of human monoclobulins (immunoglobulin G, immunoglobulin A, immunoglobulin M, Kappa and Lambda) by electrophoresis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A1660 Quality Control Materials (Analytical and Non-Analytical)
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 03, 2016
- Expiry Date
- Jun 03, 2026
About this record
Access comprehensive regulatory information for “Sebia” IT/IF Control in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 744c30cbc093ebf7cbb53123a7f483a8 and manufactured by SEBIA. The authorized representative in Taiwan is ARQon Medtech Co., Ltd..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices